{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:04:28Z","timestamp":1788185068924,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biotech &amp;amp; Bioengineering"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Bispecific antibodies are a growing class of therapeutics that simultaneously engage two targets. However, their complex molecular structures pose challenges for production in Chinese hamster ovary cells, the current industry standard for biologics manufacturing. Here we present a case study of three IgG\u2010scFv format bsAbs expressed in CHO cells, in which one candidate exhibited markedly lower titers despite high sequence homology to the other two. Using multi\u2010omics analysis (RNA sequencing, splicing prediction, codon optimization assessment, and motif screening) to investigate potential causes, we identified several likely mechanisms for poor expression, including aberrant splicing motifs, ribosome pausing sites, and suboptimal codon usage. Through targeted protein and DNA sequence engineering, we generated a revised variant with an 11\u2010fold increase in stable expression titers. This work demonstrates that integrating sequence\u2010level bioinformatic and synthetic biology diagnostics can directly improve manufacturability, providing a generalizable framework for resolving hidden expression liabilities in complex biologics.<\/jats:p>","DOI":"10.1002\/bit.70228","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:10:57Z","timestamp":1778062257000},"page":"1942-1950","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing Bispecific Antibody Expression via Multi\u2010Omics Analysis and Vector Redesign"],"prefix":"10.1002","volume":"123","author":[{"given":"Jeremy J.","family":"Gam","sequence":"first","affiliation":[{"name":"Asimov Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Chang","sequence":"additional","affiliation":[{"name":"Asimov Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinghai","family":"Zheng","sequence":"additional","affiliation":[{"name":"Asimov Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennitte","family":"Stevens","sequence":"additional","affiliation":[{"name":"Amgen, One Amgen Center Drive Thousand Oaks California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec A. K.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Asimov Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Smith","sequence":"additional","affiliation":[{"name":"Asimov Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.10517"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1268307"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0349-3"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0297-159"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bej.2020.107857"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2022.102806"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2024.2311992"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.117382"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.24415"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107610"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg306"},{"key":"e_1_2_8_14_1","first-page":"40","article-title":"Recombinant Protein Therapeutics From CHO Cells \u2010 20 Years and Counting","volume":"103","author":"Jayapal K.","year":"2007","journal-title":"Chemical Engineering Progress"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60038"},{"key":"e_1_2_8_16_1","unstructured":"*Kazusa Codon Usage Database. n.d. Codon usage table \u2014 Species code 10029. Retrieved fromhttps:\/\/www.kazusa.or.jp\/codon\/cgi-bin\/showcodon.cgi?species=10029."},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1197457"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2015.02.008"},{"key":"e_1_2_8_19_1","unstructured":"KuicK Research.2025. Bispecific Trispecific Antibodies Market Size FDA Approval Clinical Trials & Drug Sales Insight\u202f2030 [Press release]. Retrieved fromhttps:\/\/www.globenewswire.com\/news-release\/2025\/04\/04\/3056061\/0\/en\/Bispecific-Trispecific-Antibodies-Market-Size-FDA-Approval-Clinical-Trials-Drug-Sales-Insight.2030.html."},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cep.2021.108720"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0028-1"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-7188-6-26"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbac021"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626616"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1267088"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0798-677"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbac025"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6150-3-38"},{"key":"e_1_2_8_29_1","unstructured":"*R Graph Gallery. n.d. Treemap [Web page].https:\/\/r-graph-gallery.com\/treemap.html."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-337691"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.07.046"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27597-7"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/antib8030043"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1035276"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405593"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06272-x"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bej.2024.109476"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbac029"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02256-0"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty497"}],"container-title":["Biotechnology and Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bit.70228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bit.70228","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bit.70228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:47:56Z","timestamp":1782510476000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bit.70228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/bit.70228"],"URL":"https:\/\/doi.org\/10.1002\/bit.70228","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.11.10.687454","asserted-by":"object"}]},"ISSN":["0006-3592","1097-0290"],"issn-type":[{"value":"0006-3592","type":"print"},{"value":"1097-0290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"2025-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}